Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I

Molecular Endocrinology

Volumn 19, Issue 5, 2005, Pages 1304-1317

  Treins, Caroline ^a   Giorgetti Peraldi, Sophie ^a   Murdaca, Joseph ^a   Monthouël Kartmann, Marie Noëlle ^a   Van Obberghen, Emmanuel ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINYL HYDROXYLASE; COBALT CHLORIDE; GROWTH FACTOR; HYDROLASE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYLHYDROXYLASE 1; PROLYLHYDROXYLASE 2; PROLYLHYDROXYLASE 3; PROTEIN SUBUNIT; SOMATOMEDIN C; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADAPTATION; ARTICLE; CELL LINE; CELL NUCLEUS; DIABETIC RETINOPATHY; EPITHELIUM CELL; HORMONE RESPONSE; HUMAN; HUMAN CELL; HYPOXIA; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RETINA BLOOD VESSEL; SIGNAL TRANSDUCTION; TISSUE OXYGENATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARRIER PROTEINS; CELL NUCLEUS; DNA-BINDING PROTEINS; EPITHELIUM; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INSULIN-LIKE GROWTH FACTOR I; MITOGEN-ACTIVATED PROTEIN KINASES; MIXED FUNCTION OXYGENASES; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN KINASES; PROTEIN TRANSPORT; RETINA; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MAMMALIA;

EID: 17844364429     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0239     Document Type: Article

References (46)

1. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ 2001 C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54
2. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin Jr WG 2001 HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464-468
3. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ 2001 Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472
4. Masson N, Willam C, Maxwell PH, Pugh CW, Ratcliffe PJ 2001 Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J 20:5197-5206
5. Bruick RK, McKnight SL 2001 A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294:1337-1340
6. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK 2002 FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16:1466-14671
7. Hewitson KS, McNeill LA, Riordan MV, Tian YM, Bullock AN, Welford RW, Elkins JM, Oldham NJ, Bhattacharya S, Gleadle JM, Ratcliffe PJ, Pugh CW, Schofield CJ 2002 Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem 277:26351-26355
8. Mahon PC, Hirota K, Semenza GL 2001 FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15:2675-2686
9. Lieb ME, Menzies K, Moschella MC, Ni R, Taubman MB 2002 Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem Cell Biol 80:421-426
10. Oehme F, Ellinghaus P, Kolkhof P, Smith TJ, Ramakrishnan S, Hutter J, Schramm M, Flamme I 2002 Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem Biophys Res Commun 296:343-349
11. Metzen E, Berchner-Pfannschmidt U, Stengel P, Marxsen JH, Stolze I, Klinger M, Huang WQ, Wotzlaw C, Hellwig-Burgel T, Jelkmann W, Acker H, Fandrey J 2003 Intracellular localisation of human HIF-1 α hydroxylases: implications for oxygen sensing. J Cell Sci 116:1319-1326
12. Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J 2003 HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J 22:4082-4090
13. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Semenza GL 2000 Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60:1541-1545
14. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL 2001 HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21:3995-4004
15. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E 2002 Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 277:27975-27981
16. Duh E, Aiello LP 1999 Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 48:1899-1906
17. Merimee TJ, Zapf J, Froesch ER 1983 Insulin-like growth factors. Studies in diabetics with and without retinopathy. N Engl J Med 309:527-530
18. Lauszus FF, Klebe JG, Bek T, Flyvbjerg A 2003 Increased serum IGF-I during pregnancy is associated with progression of diabetic retinopathy. Diabetes 52:852-856
19. King GL, Goodman AD, Buzney S, Moses A, Kahn CR 1985 Receptors and growth-promoting effects of insulin and insulin like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75:1028-1036
20. Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, Schaeffer JM, Senger DR 1999 Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5:1390-1395
21. Punglia RS, Lu M, Hsu J, Kuroki M, Tolentino MJ, Keough K, Levy AP, Levy NS, Goldberg MA, D'Amato RJ, Adamis AP 1997 Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes 46:1619-1626
22. Miele C, Rochford JJ, Filippa N, Giorgetti-Peraldi S, Van Obberghen E 2000 Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J Biol Chem 275:21695-21702
23. Rubelte J, Ayuso E, Navarro M, Carretero A, Nacher W, Haurigot V, George MM, Llombart C, Casellas A, Costa C, Bosch A, Bosch F 2004 Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. J Clin Invest 113:1149-1157
24. Wang GL, Semenza GL 1993 Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82:3610-3615
25. Wang GL, Jiang BH, Rue EA, Semenza GL 1995 Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510-5514
26. Pugh CW, O'Rourke JF, Nagao M, Gleadle JM, Ratcliffe PJ 1997 Activation of hypoxia-inducible factor-1; definition of regulatory domains within the α subunit. J Biol Chem 272:11205-11214
27. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM 1998 Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 392:405-408
28. Gleadle JM, Ebert BL, Firth JD, Ratcliffe PJ 1995 Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am J Physiol 268:C1362-C1368
29. Pollenz RS, Sattler CA, Poland A 1994 The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Mol Pharmacol 45:428-438
30. Eguchi H, Ikuta T, Tachibana T, Yoneda Y, Kawajiri K 1997 A nuclear localization signal of human aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor 1 beta is a novel bipartite type recognized by the two components of nuclear pore-targeting complex. J Biol Chem 272:17640-17647
31. Harris TE, Lawrence Jr JC 2003 TOR signaling. Sci STKE 2003:re15
32. Semenza GL 2003 Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732
33. Richard DE, Berra E, Pouyssegur J 2000 Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells. J Biol Chem 275:26765-26771
34. Treins C, Giorgetti-Peraldi S, Murdaca J, Van Obberghen E 2001 Regulation of vascular endothelial growth factor expression by advanced glycation end products. J Biol Chem 276:43836-43841
35. Bardos JI, Chau NM, Ashcroft M 2004 Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1α expression. Mol Cell Biol 24:2905-2914
36. Kallio PJ, Okamoto K, O'Brien S, Carrero P, Makino Y, Tanaka H, Poellinger L 1998 Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1α. EMBO J 17:6573-6586
37. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L 1999 Regulation of the hypoxia-inducible transcription factor 1 a by the ubiquitin-proteasome pathway. J Biol Chem 274:6519-6525
38. Groulx I, Lee S 2002 Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Mol Cell Biol 22:5319-5336
39. Lavista-Llanos S, Centanin L, Irisarri M, Russo DM, Gleadle JM, Bocca SN, Muzzopappa M, Ratcliffe PJ, Wappner P 2002 Control of the hypoxic response in Drosophila melanogaster by the basic helix-loop-helix PAS protein similar. Mol Cell Biol 22:6842-6853
40. Masson N, Ratcliffe PJ 2003 HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels. J Cell Sci 116:3041-3049
41. Huang LE, Gu J, Schau M, Bunn HF 1998 Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95:7987-7992
42. Karni R, Dor Y, Keshet E, Meyuhas O, Levitzki A 2002 Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1α expression under normoxia. J Biol Chem 277:42919-42925
43. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL 2002 Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277:38205-38211
44. Waskiewicz AJ, Johnson JC, Penn B, Mahalingam M, Kimball SR, Cooper JA 1999 Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo. Mol Cell Biol 19:1871-1880
45. Mazure NM, Chen EY, Laderoute KR, Giaccia AJ 1997 Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90:3322-3331
46. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL 1996 Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613